Prescription Drug & Pharmacy Benefits Strategy

The contract titled Prescription Drug & Pharmacy Benefits Strategy solicits expertise to analyze pharmacy benefit structures, assess the performance of pharmacy benefit managers, and develop actionable cost-saving strategies focused on formulary optimization and specialty drug management. The work is intended to improve efficiency and reduce expenditures within the group insurance program managed by the Massachusetts Group Insurance Commission, with performance required in Boston, Massachusetts, under a subcontract arrangement. The solicitation is open for responses until September 30, 2026, and is classified under NAICS code 541618, indicating it involves management, scientific, and technical consulting services related to healthcare pharmacy operations. The scope requires a deep understanding of pharmacy benefit administration, including the evaluation of current formularies, utilization patterns, and specialty drug spending to identify redundancies, high-cost drivers, and opportunities for negotiation or alternative therapy adoption. The contractor must deliver data-driven recommendations that align with cost containment goals while maintaining quality of care, with an emphasis on measurable outcomes and sustainable savings. All deliverables must support the agency’s obligation to steward public healthcare funds effectively, and performance will likely be evaluated on the feasibility, impact, and implementation readiness of proposed strategies.